naturopathic doctor news & review
About NDNR
Razi Ann Berry and David Tallman, DC, ND, founded NDNR in 2005. For two decades, NDNR has documented, published, and disseminated case-based evidence for naturopathic and integrative practitioners worldwide, advancing clinical knowledge through practitioner-led case reports and peer-reviewed education.
Our archive holds the largest collection of applied natural medicine case reports in existence, documenting real interventions, dosages, and patient outcomes. NDNR publishes The Journal of Applied Natural Medicine, produces live and virtual summits, masterclasses, and multimedia clinical education, and is a NANCEAC-accredited continuing education provider.
NDNR serves NDs, MDs, DOs, DCs, NPs, PAs, PhDs, and allied healthcare professionals.
Razi Ann Berry has received the AANP Champion of Naturopathic Medicine Award, the Mindshare Rising Tide Award, the Mindshare Best Digital Media Award, and Corporation of the Year.
NDNR has been recognized by SCNM, CNDA, OANP, and NYANP, the Foundations Project and Mindshare. Since 2014, NDNR has hosted the annual Physician Choice Awards.
NDNR 20 Years of Publishing
Key milestones from 2005 to today
Custom Publishing
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Featured News
Antibiotic Use And Childhood Obesity
A new study published in the International Journal of Obesity links antibiotic use to childhood body mass index trajectory. The study was comprised of children aged 3-18 and the researchers used mixed effects linear regression to model associations of antibiotic...
The Impact of High Fructose Diet on Offspring
According to a new study by the Society for Maternal-Fetal Medicine, researchers discuss their findings on the effects of antenatal exposure to a high fructose diet on the offspring’s development of metabolic syndrome-like phenotype and cardiovascular disease later in...
Critical Path Institute Secures Regulatory Support For Skeletal Muscle Safety Biomarkers
TUCSON, Ariz., April 13, 2015 – The Critical Path Institute (C-Path) announced today that both the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have issued Biomarker Letters of Support for four skeletal muscle safety biomarkers...
April 2015 | Autoimmune and Allergy
Volume 11 Issue 4 Allergic Rhinitis: A Review & Naturopathic Treatments.....................>>cover Darin Ingels, ND Autoimmune Disease: Lessons from the Field of Transplantation......................>>bottom of cover Jenna Henderson, ND The 4 Rs of...
Cesca Therapeutics Management Provides Update on Clinical Trials for Critical Limb Ischemia ("CLI") and Acute Myocardial Infarction ("AMI")
RANCHO CORDOVA, Calif., April 10, 2015 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (KOOL), an autologous cell-based regenerative medicine company, today announced a corporate update on Cesca's clinical trial program in CLI and AMI. Critical Limb Ischemia As previously...
GOLD AF Registry to Capture Real-World Insights Using Medtronic Phased RF Ablation to Treat Patients with Atrial Fibrillation
DUBLIN - April 7, 2015 - Medtronic plc (NYSE: MDT) today announced the first patient enrollment in the GOLD AF Registry, a first-of-its-kind, prospective, observational clinical study of its Phased Radiofrequency (RF) Ablation technology for treating patients with...